as nasdaq agio industry pharmaceuticals founded 2008 2008 headquarters cambridge massachusetts united states key people david schenkein ceo 2012 website agios.com footnotes references foundation 1 agios pharmaceuticals is a public american pharmaceutical company focused on developing small molecule anti cancer therapeutics targeting cancer cell metabolism via the growth factor pathway . 1 2 among the proteins under investigation by the company are idh1 and idh2 . 3 the company was founded in 2008 or 2007 3 by lewis cantley tak mak and craig thompson . agios is a delaware corporation headquartered in cambridge massachusetts . 1 4 the company tendered an initial public offering in july 2013 . 5 table 1 in 2012 agios was named among the defendants in a lawsuit against one of its founders craig thompson alleging that thompson used research illegally taken from the abramson family cancer research institute in research at agios . 3 in may 2016 the company announced it would launch partnership with celgene developing metabolic immuno oncology therapies . the deal could net more than 1 billion for agios . 6 corporate governance edit as of february 2012 update agios ceo was david schenkein . 3 agios was established as a private company and converted to a public company with its initial public offering in july 2013 and subsequent listing on nasdaq . 3 5 references edit a b c pfeffer cary g. 2012 . the biotechnology sector . in burns lawton r. the business of healthcare innovation google ebook . cambridge united kingdom cambridge university press . pp. 224 228 . isbn 9781107024977 . anton ted 2013 . chapter 13 . the longevity seekers google ebook . university of chicago press . p. 163 . isbn 9780226020938 . a b c d e pollack andrew february 5 2012 . sloan kettering chief is accused of taking research . the new york times . agios pharmaceuticals inc. . edgar . form 10 k. u.s. securities and exchange commission . march 18 2014 . commission file number 001 36014 . a b huggett brady december 2013 . burning bright . nat . biotechnol . 31 12 . pp. 1068 71 . celgene agios launch 1b metabolic immuno oncology alliance gen news highlights gen . gen. notes edit this article about a medical pharmaceutical or biotechnological corporation or company is a stub . you can help wikipedia by expanding it . v t e retrieved from https en.wikipedia.org w index.php title agios pharmaceuticals & oldid 720942177 categories pharmaceutical companies established in 2008companies based in cambridge massachusettscompanies listed on nasdaqmedical company stubshidden categories articles containing potentially dated statements from february 2012all articles containing potentially dated statementsall stub articles navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page print export create a bookdownload as pdfprintable version languages add links this page was last modified on 18 may 2016 at 21 38 . text is available under the creative commons attribution sharealike license ; additional terms may apply . by using this site you agree to the terms of use and privacy policy . wikipedia is a registered trademark of the wikimedia foundation inc. a non profit organization . privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view